Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

AltaRex awaits Canadian approval to begin Ovarex phase II/III trials

Aug. 23, 1996

European approval sought for new Rebif indications

Aug. 23, 1996

U.S. patent will issue covering GLIOMAB-H

Aug. 16, 1996

BEC2, ImClone Systems' therapeutic vaccine protected under U.S. patent

Aug. 9, 1996

Larifane shown effective in cervical dysplasia/cancer patients

July 26, 1996

Humanized CD38 antibodies for cancer/autoimmune disease treatment

July 26, 1996

Multikine enters Canadian phase I/II trial

July 12, 1996

Antitumor vaccines described by University of Pennsylvania

July 5, 1996

Human Genome Sciences reports discovery of TNF-gamma

July 5, 1996

Virulizin undergoes phase I/II in pancreatic cancer

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026